The Change of Antituberculosis Drug Resistance Rate in Edirne Region in 1996 and 2006

Basit Öğe Kaydı
dc.contributor.authorPerincek, Gokhan
dc.contributor.authorTabakoglu, Erhan
dc.contributor.authorOtkun, Metin
dc.contributor.authorOzdemir, Levent
dc.date.accessioned2025-01-27T21:03:46Z
dc.date.available2025-01-27T21:03:46Z
dc.date.issued2010
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractObjective: To establish the change in the ratio of the a ntituherculosis drug resistance in Edirne region between 1996-2006. Materials and Methods: The patients, who were detected with Mycobacterium tuberculosis proliferation in the cultures, were enrolled to the study between 1996-2006. The patients, who were diagnosed with isoniazid, rifampisin, ethambutol, streptomycin and multi-drug resistance were selected and their data of was uploaded to SPSS software in order to perform statistical analysis. Results: We found the Mycobacterium tuberculosis proliferation of cultures in 70 patients in 1996, whew. 21 patients had isoniazid, 8 patients had rifampicin, 7 patients had ethambutol, r patients had streptomycin, and 5 patients had multi Burg resistance. En 2006, illyrobacterium tuberculosis proliferation was established in 47 patients. Of these, 11 patients had isoniazid, 8 had rifampisin, one patient had ethambutol, 2 patients had streptomycin and 3 patients had multi-durg resistance. We compared the changes in the resistance figures and found a decrease: of drug resistance as follows: in isoniazid, from 21 patients (301Y0) to 11 patients (23.4%); in rifampisin, from 8 patients (11%) to 4 patients (8.5%0; in ethambutol, from 7 patients (13'Yo) to one patient (2.1`,0; in streptomycin, from r patients (39%) to 2 patients (4.3%); in multi drug, from 5 patients (7%) to 3 patients (6.4`%). Conclusion: Although statistically significant decrease of drug resistance was not found in isoniazid, rifampisin, ethambutol and multi-drug, a significant drug resistance \vas estabished in streptomycin in Edirne region during the 10 years period.
dc.identifier.endpage133
dc.identifier.issn2148-3620
dc.identifier.issn2148-5402
dc.identifier.issue3
dc.identifier.startpage129
dc.identifier.urihttps://hdl.handle.net/20.500.12428/27442
dc.identifier.volume12
dc.identifier.wosWOS:000421868500005
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.language.isotr
dc.publisherWolters Kluwer Medknow Publications
dc.relation.ispartofEurasian Journal of Pulmonology
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20250125
dc.subjectantituberculosis drugs resistance
dc.subjectMycobacterium tuberculosis complex
dc.titleThe Change of Antituberculosis Drug Resistance Rate in Edirne Region in 1996 and 2006
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu